Syndax Pharmaceuticals SNDX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's net margin?
- Syndax Pharmaceuticals (SNDX) reported net margin of -111.9% in Q1 2026.
- How has Syndax Pharmaceuticals's net margin changed year-over-year?
- Syndax Pharmaceuticals's net margin increased by 85.2% year-over-year, from -757.5% to -111.9%.
- What is the long-term trend for Syndax Pharmaceuticals's net margin?
- Over 3 years (2020 to 2025), Syndax Pharmaceuticals's net margin has grown at a -67.5% compound annual growth rate (CAGR), from -4,822.5% to -165.4%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.